<DOC>
	<DOCNO>NCT00935922</DOCNO>
	<brief_summary>The aim study compare effect flaxseed atherogenic lipid , plasma inflammatory marker , insulin sensitivity . We hypothesize flaxseed omega-3 fatty acid improve lipid profile ( decrease triglyceride , total LDL-cholesterol increase HDL-cholesterol ) . Flaxseed rich dietary source lignan secoisolariciresinol diglucoside ( SDG ) . Lignans estrogens find plant source behave similar endogenous estrogen associate cardiovascular benefit due antioxidant activity . Therefore , also hypothesize flax-lignans cause significant decrease LDL oxidation inflammatory marker C-reactive protein ( CRP ) , interleukin-6 ( IL-6 ) , IL-1B , serum fatty acid bind protein 4 ( FABP-4 ) , serum amyloid attach high density lipoprotein ( HDL-SAA ) .</brief_summary>
	<brief_title>CCRC : Understanding Effects Omega-3 Fatty Acids Versus Lignans Flaxseed Metabolic Inflammatory Markers Leading Diabetes Cardiovascular Disease</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Body Weight</mesh_term>
	<criteria>Men postmenopausal woman 4065 year age range . Body Mass Index range 2539 Women premenopausal Smoking Diabetes Cancer Gout Untreated thyroid disease Kidney Disease Liver Disease Use lipid lower drug Use insulin sensitize drug Use ACE inhibitor blood pressure lower medication Use counter prescription antiobesity medication Weight loss 10 % within last 12 month</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Flaxseed</keyword>
	<keyword>Weight loss</keyword>
	<keyword>Heart health</keyword>
	<keyword>Diabetes</keyword>
</DOC>